Goldman Sachs raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $41 from $36 and keeps a Neutral rating on the shares.

The demise of the pharmaceutical sales representative has been greatly ... one another would not have been as easy. However, many jobs cannot be simply copied and pasted into the digital world.

The pharmaceutical giant expects overall sales and core earnings per share to rise by a high-teens percentage at constant ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price ...

Ironwood Pharmaceuticals is a smaller company than it was in 2016, when Life Science Leader wrote a feature article about its ...

Amneal Pharmaceuticals logged a big jump in revenue from gains in its generic and specialty drug portfolio, though higher interest costs swung it to a net loss. The drugmaker posted a loss of $ ...

The Electrolit company has revealed plans to construct a $400 million state-of-the-art manufacturing facility in Waco.

Brian Sokalsky, 46, of Margate was accused of prescribing costly compounded medications as part of a conspiracy with a pharmaceutical sales representative. The drugs, which were not medically ...

Bayer's shares plunged to a 20-year low Tuesday after the German chemicals giant cut its earnings outlook and posted a worse-than-expected loss on woes related to its troubled agrochemicals division.

Rieger and Kirby will help oversee and implement operational changes, which were announced last month, including reducing its number of sales territories and cutting jobs. These changes, expected to ...